神經補綴的全球市場-市場規模，市場區隔，展望，收益預測:各類型，各技術，各用途，各地區(2022年～2028年)

全球神經補綴的市場規模在2017年估算為約50億美元，到2022年達到約80億美元，到2028年前將達到約150億美元，在預測期間內預計將以12％的年複合成長率成長。神經系統疾病的增加正在推動市場增長。然而神經假體產品的高成本阻礙了市場的增長。

本報告提供全球神經補綴市場相關調查分析，提供主要的趨勢，競爭情形，市場分析等系統性資訊。

目錄

第1章 摘要整理

• 全球神經補綴市場成長實際成果與預測的亮點
• 市場趨勢，課題，競爭的亮點
• 市場收益佔有率的亮點:各市場區隔

第2章 市場概要與影響成長的主要趨勢

• 全球神經補綴市場分類
• 產業的價值鏈
• 全球神經補綴市場上主要企業的生態系統
• 政府的法規與開發
• 影響市場的主要推動因素與課題
• COVID-19對全球神經補綴市場帶來的影響
• 神經補綴市場成長實際成果(2017年～2021年):各市場區隔類型
• 各類型
• 各技術
• 各用途
• 各地區
• 全球神經補綴市場成長實際成果與預測(2017年～2028年)
• 重要點

第3章 全球市場區隔，成長實際成果，展望，預測:各類型

• 市場定義-市場區隔:各類型
• 市場收益佔有率，成長實際成果，展望，預測(2017年～2028年):各類型
• 輸出
• 輸入
• 市場區隔的重要點:各類型

第4章 全球市場區隔，成長實際成果，展望，預測:各技術

• 市場定義-市場區隔:各技術
• 市場收益佔有率，成長實際成果，展望，預測(2017年～2028年):各技術
• 腦深部刺激
• 迷走神經刺激
• 脊髓刺激
• 薦椎神經刺激
• 市場區隔的重要點:各技術

第5章 全球市場區隔，成長實際成果，展望，預測:各用途

• 市場定義-市場區隔:各用途
• 市場收益佔有率，成長實際成果，展望，預測(2017年～2028年):各用途
• 運動神經補綴
• 生理的障礙
• 認知障礙
• 市場區隔的要點:各用途

第6章 產業/競爭分析-競爭情形

• 企業(競爭企業)的類型與競爭佔有率
• 全球神經補綴的競爭相關波特的五力分析
• 影響市場成長的全球神經補綴部門的主要開發
• 全球神經補綴市場上主要競爭的比較(2021年)
• 全球神經補綴市場上主要競爭的比較(2021年):類型範圍
• 全球神經補綴市場上主要競爭的比較(2021年):技術範圍
• 全球神經補綴市場上主要競爭的比較(2021年):用途範圍
• 全球神經補綴市場上主要競爭的比較(2021年):地區範圍
• 競爭情形的重要點

第7章 主要競爭企業簡介(企業概要，產品報價環，優勢和弱點的分析)

• Abbott
• Boston Scientific Corporation
• Cochlear Ltd
• Cyberonics, Inc.
• LivaNova PLC
• Medtronic
• NeuroPace, Inc.
• BioRegio STERN Management GmbH
• Second Sight
• Sonova

第8章 地區分析與主要國家的市場成長實際成果，展望，預測

• 主要國家的宏觀經濟要素比較
• 全球市場的收益佔有率，成長實際成果，展望與預測(2017年～2028年):各地區
• 主要國家的市場分析，成長實際成果，展望與預測
• 北美-神經補綴市場分析
• 歐洲- 神經補綴市場分析
• 亞太地區- 神經補綴市場分析
• 南美，中東，非洲-神經補綴市場分析

第9章 產業專家的意見/展望

• 專家和經營幹部關於市場現狀和未來前景的重要聲明/引述

第10章 分析師的推薦

• 分析師對確定的主要機會和從機會中獲益的潛在策略性建議

第11章 附錄

• 調查手法-市場規模的估計，預測，及健全性檢查的方法
• 樣品討論指南

免責聲明

Market Overview:

A neuroprosthetic (also called as neural prosthetic) is any device that can enhance the input or output of a neural system. The most successful neuroprosthetic devices developed to date are cochlear implants for patients with hearing impairment, and prosthetic devices for amputees. Neuroprosthetics encompass a variety of artificial devices or systems that can be used to enhance the motor, sensory, cognitive, visual, auditory, and communicative deficits that arise from acquired brain injuries.

According to Ken Research Analysis, the Global Neuroprosthetics Market was valued at ~US$ 5 billion in 2017. It is estimated to be ~US$ 8 billion in 2022 and is forecasted to reach a market size of ~US$ 15 billion, growing at a CAGR of ~12% owing to the rising demand from the manufacturing industry.

The increasing prevalence of neurological disorders is driving the growth of the market. Neuroprosthetics are used when other treatments are unable to cure a disease or condition. The adoption of neuroprosthetic technologies, such as SCS, DBS, Vagus nerve stimulation (VNS), and sacral cord stimulation, is growing in developed countries such as the US, Canada, and Australia, boosting the growth of the overall market.

The high cost of neuroprosthetic products is challenging the neuroprosthetics market growth. Cochlear implants are more expensive than hearing aids. The high cost of surgery and difficulty in maintenance is anticipated to pose a significant challenge during the forecast time. The high cost of the implants, as well as the problem of maintaining them, has hampered market growth.

The market was significantly impacted by the COVID-19 pandemic during the first half of 2020, due to a major drop in non-urgent treatments such as cochlear implant surgery around the world. With the increase in COVID-19 cases, governments around the world implemented various safety measures such as lockdowns and stringent guidelines, disrupting the international supply chain of cochlear implants.

Scope of the Report:

The Neuroprosthetics market is segmented by type, technique, application, and region. In addition, the report also covers the market size for each of the four regions' Neuroprosthetics market. The revenue used to size and forecast the market for each segment is US$ billion.

Type

Output Neural Prosthetics

Motor Prosthetics

Cognitive Prosthetics

Input Neural Prosthetics

Cochlear Implants

Bionic Eye/Retinal Implants

Technique

Deep Brain Stimulation

Vagus Nerve Stimulation

Spinal Cord Stimulation

Sacral Nerve Stimulation

Application

Motor Neural Prosthetics

Parkinson's disease

Epilepsy

Physiological Disorders

Auditory Processing Disorders

Ophthalmic Disorders

Cardiovascular Disorders

Urology Disorders

Cognitive Disorders

Alzheimer's Disease

Paralysis

Region

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Spain, Italy, Rest of Europe)

Asia Pacific (China, Japan, South Korea, India, Indonesia, Australia, Rest of Asia Pacific)

LAMEA (Latin America, Middle East, Africa)

Key Players

Abbott

Boston Scientific Corporation

Cochlear Ltd

Cyberonics, Inc.

LivaNova PLC

Medtronic

NeuroPace, Inc.

BioRegio STERN Management GmbH

Second Sight

Sonova

Key Trends by Market Segment

By Type: The input neural prosthetics segment held the largest market share in the global neuroprosthetics market in 2021, owing to the growing burden of hearing loss and advancements in technology for the development of novel devices.

The input neural prosthetics include a cochlear Implant and bionic eye/retinal Implant. These are electronic devices that can help to provide a sense of sound to a person who is profoundly deaf or severely hard of hearing.

The motor prosthetics segment held a significant share of the market owing to the rising adoption of bladder control implants and brain-computer interfaces for paraplegic and lateral sclerosis patients.

By Technique: The spinal cord stimulation segment held the largest market share in the global neuroprosthetics market in 2021, due to the rising prevalence of chronic pain among the population across the globe.

The increasing failed back syndrome, and complex regional pain syndrome are projected to increase the demand for spinal cord stimulation technology-based neuroprosthetics devices.

The recent product approvals based on spinal cord stimulation technology is likely to propel the neuroprosthetics market in the coming future. For instance, in July 2021, Nevro received FDA approval for its 10 kHz high-frequency spinal cord stimulation therapy for the treatment of chronic pain associated with Painful Diabetic Neuropathy (PDN).

By Application: The motor neural prosthetics segment held the largest market share in the global Neuroprosthetics market in 2021, owing to its rising adoption in parkinson's and epilepsy coupled with the rising prevalence of these aforementioned disorders.

Cognitive disorders segment is expected to hold the highest CAGR during the forecast period, owing to the rising incidences of Alzheimer's disease and severe depression.

The introduction of advanced implants capable of calculating limb trajectory and stimulating motor control for movements, used in the treatment of paralysis are further anticipated to augment the market growth over the forecast period.

By Region: North Americaheld the largest market share among all other regions within the global neuroprosthetics market in 2021, due to the supporting government policies to augment the growth of the region.

The large share of the region is attributed to the presence of factors, such as government & private funding and well-established healthcare facilities.

In the USA, more than a thousand people are living with spinal cord injury and half of these people cannot move from the neck which is expected to drive the treatment through neuroprosthetics.

Competitive Landscape

The Global Neuroprosthetics Market is highly competitive with ~150 players, including globally diversified players, regional players, and many country-niche players. Most of the regional players are the developers of Neuroprosthetics used in various end-user industries.

Country-niche players constitute ~25% of the total number of competitors, while regional players dominate representing ~45% of total competitors. Some of the major players in the market include Abbott, Boston Scientific Corporation, Cochlear Ltd, Cyberonics, Inc., LivaNova PLC, Medtronic, NeuroPace, Inc., BioRegio STERN Management GmbH, Second Sight, Sonova, among others.

Recent Developments Related to Major Players and Organizations

In July 2022, Sensorion declared that regulatory authorities in Australia have given their approval for the start of a Proof of Concept (POC) clinical trial of SENS-401 (Arazasetron) in patients who are scheduled for cochlear implantation.

In January 2022, TODOC, a Korean company that specializes in neural prosthesis and neuromodulation systems, announced the introduction of its artificial cochlear implant 'SULLIVAN' at the "CES 2022" in Las Vegas.

Conclusion

The Global Neuroprosthetics Market witnessed a negative impact due to COVID-19 owing to the strict regulations in several countries that temporarily halted all types of processes and shut down all the major industries. Input Neural Prosthetics, which include cochlear implants and bionic eye/retinal implants are the most common type of neuroprosthetics. Majorly, the spinal cord stimulation neuroprosthetics technique is used for treating cognitive disorders such as Alzheimer's disease and paralysis. Though the market is competitive with over ~150 participants, regional players control the dominant share in the market and country-niche players also hold a significant share.

Note: This is an On-Demand/Planned report, so the figures quoted here for market size estimate, forecast, growth, segment share, and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients and report delivered within a maximum of 2 working weeks.

Key Topics Covered in the Report

Snapshot of Global Neuroprosthetics Market

Industry Value Chain and Ecosystem Analysis

Market size and Segmentation of the Global Neuroprosthetics Market

Historic Growth of Overall Global Neuroprosthetics Market and Segments

Competition Scenario of the Market and Key Developments of Competitors

Porter's 5 Forces Analysis of Global Neuroprosthetics Industry

Overview, Product Offerings, Strengths, & Weaknesses of Key Competitors

Covid-19 Impact on the Overall Global Neuroprosthetics Market

Future Market Forecast and Growth Rates of the Global Neuroprosthetics Market and Segments

Analysis of Global Neuroprosthetics Market

Major Production/Supply and Consumption/Demand Hubs within Each Region

Major Country-wise Historic and Future Market Growth Rates of the Total Market and Segments

Overview of Notable Emerging Competitor Companies within Each Region

Notable Key Players Mentioned in the Report

Abbott

Boston Scientific Corporation

Cochlear Ltd

Cyberonics, Inc.

LivaNova PLC

Medtronic

NeuroPace, Inc..

BioRegio STERN Management GmbH

Second Sight

Sonova

Notable Emerging Companies Mentioned in the Report

iotaMotion, Inc.

Hemideina

TODOC Co., Ltd.

ADVANCED OPTRONICS

Restohearing

Key Target Audience - Organizations and Entities Who Can Benefit by Subscribing This Report

Neuroprosthetics Manufacturers

Neuroprosthetics Suppliers

Output Neural Prosthetics Manufacturers

Input Neural Prosthetics Manufacturers

Deep Brain Stimulation Neuroprosthetics Manufacturers

Vagus Nerve Stimulation Neuroprosthetics Manufacturers

Spinal Cord Stimulation Neuroprosthetics Manufacturers

Sacral Nerve Stimulation Neuroprosthetics Manufacturers

Emerging and Startup Companies in Neuroprosthetics

Different Types of Neuroprosthetics Manufacturing Hubs

Government Ministries and Departments of Healthcare Industry

Healthcare Regulatory Organizations

Healthcare Research Institutes

Importers and Distributors of Neuroprosthetics

Financial Organizations focused on Healthcare Industry

PE and VC Firms focused on Healthcare Industry

Period Captured in the Report

Historical Period: 2017-2021

Forecast Period: 2022E-2028F

Frequently Asked Questions

What is the Study Period of this Market Report?

The Global Neuroprosthetics Market is covered from 2017-2028 in this report, which includes a forecast for the period (2022-2028).

What is the Future Growth Rate of the Global Neuroprosthetics Market?

The global neuroprosthetics market is expected to witness a CAGR of ~12% over the next 6 years.

What are the Key Factors Driving the Global Neuroprosthetics Market?

The rising prevalence of hearing disorders is one of the primary drivers for the growth of the global neuroprosthetics market.

Which is the Largest Application Segment within the Global Neuroprosthetics Market?

The cognitive disorders segment held the largest share of the global neuroprosthetics market in 2021.

Who are the Key Players in the Global Neuroprosthetics Market?

Abbott, Boston Scientific Corporation, Cochlear Ltd, Cyberonics, Inc., LivaNova PLC, Medtronic, NeuroPace, Inc.., BioRegio STERN Management GmbH, Second Sight, Sonova, among others are the major companies operating in Global neuroprosthetics Market.

Table Of Contents

Scope

1. Executive Summary

• 1.1 Highlights of Global Neuroprosthetics Market Historic Growth & Forecast
• 1.2 Highlights of Market Trends, Challenges, and Competition
• 1.3 Highlights of Market Revenue Share by Segments

2. Market Overview and Key Trends Impacting Growth

• 2.1 Global Neuroprosthetics Market Taxonomy
• 2.2 Industry Value Chain
• 2.3 The Ecosystem of Major Entities in the Global Neuroprosthetics Market
• 2.4 Government Regulations & Developments
• 2.5 Key Growth Drivers & Challenges Impacting the Market
• 2.6 COVID-19 Impact on Global Neuroprosthetics Market
• 2.7 Total Neuroprosthetics Market Historic Growth by Segment Type, 2017-2021

2.7.1 By Type

2.7.2 By Technique

2.7.3 By Application

2.7.4 By Region

• 2.8 Total Global Neuroprosthetics Market Historic Growth and Forecast, 2017-2028
• 2.9 Key Takeaways

3. Global - Market Segmentation by Type, Historic Growth, Outlook & Forecasts

• 3.1 Market Definition - Segmentation by Type
• 3.2 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Type, 2017-2028

3.2.1 Output Neural Prosthetics

3.2.2 Input Neural Prosthetics

• 3.3 Key Takeaways from Market Segmentation by Type

4. Global - Market Segmentation by Technique, Historic Growth, Outlook & Forecasts

• 4.1 Market Definition - Segmentation by Technique
• 4.2 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Technique, 2017-2028

4.2.1 Deep Brain Stimulation

4.2.2 Vagus Nerve Stimulation

4.2.3 Spinal Cord Stimulation

4.2.4 Sacral Nerve Stimulation

• 4.3 Key Takeaways from Market Segmentation by Technique

5. Global - Market Segmentation by Application, Historic Growth, Outlook & Forecasts

• 5.1 Market Definition - Segmentation by Application
• 5.2 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Application, 2017-2028

5.2.1 Motor Neural Prosthetics

5.2.2 Physiological Disorders

5.2.3 Cognitive Disorders

• 5.3 Key Takeaways from Market Segmentation by Application

6. Industry / Competition Analysis - Competitive Landscape

• 6.1 Types of Players (Competitors) & Share of Competition
• 6.2 Porter's 5 Forces Analysis of Global Neuroprosthetics Competitors
• 6.3 Key Developments in the Global Neuroprosthetics Sector Impacting Market Growth
• 6.4 Comparison of Leading Competitors within Global Neuroprosthetics Market, 2021
• 6.5 Comparison of Leading Competitors within Global Neuroprosthetics Market by Coverage of Type, 2021
• 6.6 Comparison of Leading Competitors within Global Neuroprosthetics Market by Coverage of Technique, 2021
• 6.7 Comparison of Leading Competitors within Global Neuroprosthetics Market by Coverage of Application, 2021
• 6.8 Comparison of Leading Competitors within Global Neuroprosthetics Market by Coverage of Region, 2021
• 6.9 Key Takeaways from Competitive Landscape

7. Key Competitor Profiles (Company Overview, Product Offerings, and Strengths & Weaknesses Analysis)

• 7.1 Abbott
• 7.2 Boston Scientific Corporation
• 7.3 Cochlear Ltd
• 7.4 Cyberonics, Inc.
• 7.5 LivaNova PLC
• 7.6 Medtronic
• 7.7 NeuroPace, Inc..
• 7.8 BioRegio STERN Management GmbH
• 7.9 Second Sight
• 7.10 Sonova

8. Geographic Analysis & Major Countries Market Historic Growth, Outlook, and Forecasts

• 8.1 Major Countries Comparison of Macroeconomic Factors
• 8.2 Global- Market Revenue Share, Historic Growth, Outlook and Forecasts by Region, 2017-2028
• 8.3 Major Countries Market Analysis, Historic Growth, Outlook & Forecasts
• 8.4 North America - Neuroprosthetics Market Analysis

8.4.1 Major Production and Consumption Hubs in North America

8.4.2 Notable Emerging Neuroprosthetics Companies in North America

8.4.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Type, 2017-2028

8.4.4 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technique, 2017-2028

8.4.5 Market Revenue Share, Historic Growth, Outlook and Forecasts by Application, 2017-2028

8.4.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028

USA

Canada

Mexico

• 8.5 Europe - Neuroprosthetics Market Analysis

8.5.1 Major Production and Consumption Hubs in Europe

8.5.2 Notable Emerging Neuroprosthetics Companies in Europe

8.5.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Type, 2017-2028

8.5.4 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technique, 2017-2028

8.5.5 Market Revenue Share, Historic Growth, Outlook and Forecasts by Application, 2017-2028

8.5.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028

Germany

UK

France

Spain

Italy

Rest of Europe

• 8.6 Asia Pacific - Neuroprosthetics Market Analysis

8.6.1 Major Production and Consumption Hubs in the Asia Pacific

8.6.2 Notable Emerging Neuroprosthetics Companies in the Asia Pacific

8.6.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Type, 2017-2028

8.6.4 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technique, 2017-2028

8.6.5 Market Revenue Share, Historic Growth, Outlook and Forecasts by Application, 2017-2028

8.6.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028

China

Japan

South Korea

India

Indonesia

Australia

Rest of Asia Pacific

• 8.7 LAMEA - Neuroprosthetics Market Analysis

8.7.1 Major Production and Consumption Hubs in LAMEA

8.7.2 Notable Emerging Neuroprosthetics Companies in LAMEA

8.7.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Type, 2017-2028

8.7.4 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technique, 2017-2028

8.7.5 Market Revenue Share, Historic Growth, Outlook and Forecasts by Application, 2017-2028

8.7.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Sub-Regions, 2017-2028

Latin America

Middle East

Africa

9. Industry Expert's Opinions/Perspectives

• 9.1 Notable Statements/Quotes from Industry Experts and C-Level Executives on Current Status and Future Outlook of the Market

10. Analyst Recommendation

• 10.1 Analyst Recommendations on Identified Major Opportunities and Potential Strategies to Gain from Opportunities

11. Appendix

• 11.1 Research Methodology - Market Size Estimation, Forecast, and Sanity Check Approach
• 11.2 Sample Discussion Guide

Disclaimer